| ISIN | CH1402922988 |
|---|---|
| Valor Number | 140292298 |
| Bloomberg Global ID | ASSWEQA SW |
| Fund Name | AS SWISS EQUITY FUND - AS Swiss Equity Plus A |
| Fund Provider |
AS Investment Management
Genève, Switzerland Phone: +41 22 716 52 00 E-Mail: info@as-im.com Web: www.as-im.com |
| Fund Provider | AS Investment Management |
| Representative in Switzerland | |
| Distributor(s) |
Banque Cantonale Vaudoise Lausanne Phone: +41 21 212 10 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
| Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
| Investment Strategy *** | |
| Peculiarities |
| Current Price * | 102.84 CHF | 15.01.2026 |
|---|---|---|
| Previous Price * | 102.34 CHF | 08.01.2026 |
| 52 Week High * | 106.91 CHF | 13.02.2025 |
| 52 Week Low * | 94.50 CHF | 10.04.2025 |
| NAV * | 102.84 CHF | 15.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 88,888,138 | |
| Unit/Share Assets *** | 88,888,138 | |
| Trading Information SIX | ||
| YTD Performance | +0.94% |
31.12.2025 - 15.01.2026
31.12.2025 15.01.2026 |
|---|---|---|
| 1 month | +1.39% |
18.12.2025 - 15.01.2026
18.12.2025 15.01.2026 |
| 3 months | +2.18% |
16.10.2025 - 15.01.2026
16.10.2025 15.01.2026 |
| 6 months | +3.63% |
17.07.2025 - 15.01.2026
17.07.2025 15.01.2026 |
| 1 year | +1.59% |
16.01.2025 - 15.01.2026
16.01.2025 15.01.2026 |
| 2 years | +2.84% |
09.01.2025 - 15.01.2026
09.01.2025 15.01.2026 |
| 3 years | - | - |
| 5 years | - | - |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| UBS Group AG Registered Shares | 13.59% | |
|---|---|---|
| Novartis AG Registered Shares | 8.65% | |
| Roche Holding AG | 8.40% | |
| ABB Ltd | 6.58% | |
| Zurich Insurance Group AG | 5.68% | |
| Swiss Re AG | 4.92% | |
| Geberit AG | 4.26% | |
| Givaudan SA | 3.96% | |
| Lonza Group Ltd | 2.97% | |
| Swiss Life Holding AG | 2.86% | |
| Last data update | 30.09.2025 | |
| TER | 1.59% |
|---|---|
| TER date | 31.10.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.50% |
| Ongoing Charges *** | |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |